Prospeo
Hero Section BackgroundHero Section Background
enGene

enGene Revenue

Biotechnology ResearchFlag of US99 High Street, Boston, United States101-200 Employees

$

enGene revenue & valuation

Annual revenue$11,400,000
Revenue per employee$86,000
Estimated valuation?$36,500,000
Total funding$265,700,000

Key Contacts at enGene

Flag of US

Joan Connolly

Chief Technology Officer

Flag of US

Ron Cooper

Chief Executive Officer | Member, Board of Directors

Flag of US

Joanna Opalinski

Sr. Executive Assistant to the Chief Executive Officer and G&A Executives

Company overview

Headquarters99 High Street, Boston, Massachusetts 02110, US
Phone number+16042214362
Websites
NAICS541714
SIC738
Keywords
DNA, Oncology, Drug Development, RNA, Urology, Bladder Cancer, Nmibc, Non-Muscle Invasive Bladder Cancer, Genetic Medicines, Non-Viral Gene Therapy, Gene-Based Immunotherapy, Mucosal Tissues
Founded1999
Employees101-200
Socials

enGene Email Formats

enGene uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@engeneinc.com), used 95.2% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@engeneinc.com
95.2%
{first initial}{last name}
jdoe@engeneinc.com
2.4%
{last name}{last name}
doedoe@engeneinc.com
2.4%

About enGene

enGene (Nasdaq: ENGN) is a clinical-stage biotechnology company aiming to mainstream gene-based immunotherapy by advancing non-viral treatments that can be delivered locally to the site of disease—starting with non-muscle invasive bladder cancer (NMIBC) and expanding beyond. Founded in Canada, with a United States headquarters located in Boston, we are developing innovative solutions with the goal of reducing treatment burden and improving patient outcomes. To learn more about enGene visit our website: enGene.com. We are currently enrolling select patients with NMIBC in our LEGEND clinical trial. We have sites in the United States, Canada, Europe and the Asia-Pacific region. For more information, please visit TheLegendStudy.com.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry
Director
Senior

Employees by Department

enGene has 54 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore enGene's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2020-11-299N/A
2024-01-2212$22,500,000
2024-03-1414$200,000,000
2024-11-2514$43,200,000

Funding Insights

$265,700,000

Total funding amount

$43,200,000

Most recent funding amount

4

Number of funding rounds

Frequently asked questions

enGene is located in 99 High Street, Boston, US.
You can reach enGene at +16042214362.
enGene generates an estimated annual revenue of $11,378,815. This revenue figure reflects the company's market position and business performance in its industry.
enGene has an estimated valuation of $36,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
enGene was founded in 1999, making it 27 years old. The company has established itself as a significant player in its industry over this time.
enGene has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.
enGene has raised a total of $265,700,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles